Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Arbutus Biopharma
Biotech
Drugs up for sale, on the shelf in biotech pipeline clear-outs
Xilio Therapeutics, Protagonist Therapeutics, Arbutus Biopharma and Aptinyx all decided they have better uses for their cash.
Nick Paul Taylor
Nov 9, 2022 9:40am
Functional cure setback triggers layoffs at Assembly
Jul 21, 2022 9:14am
Antios rocked as hepatitis B safety signal sparks clinical hold
May 25, 2022 8:42am
Moderna patent case spurs concern for COVID-19 vaccine progress
Jul 24, 2020 8:50am
Arbutus axes another hep B program due to safety worries
Feb 11, 2020 10:10am
Arbutus cans hep B program after 2 healthy people fall ill
Oct 4, 2019 9:58am
